Latest Breaking News On - Inactivated vaccine - Page 10 : comparemela.com

28.51% CAGR , mRNA Vaccines & Therapeutics Market Size, Share, significant growth Rate, Trends 2026 by Brandessence Market Research Pune, India, Dec. 15, 2020 (GLOBE NEWSWIRE) The global demand for mRNA vaccines & therapeutics market size, in terms of revenue, was worth of USD 587.7 million in 2019 and is expected to reach USD 2911.9 million in 2026, growing at a CAGR of 28.51% from 2020 to 2026. The global mRNA vaccines & therapeutics market is expected to grow at significant growth rate due to number of driving factor. Messenger Ribonucleic Acid (mRNA) refers to a single protein-coding gene in the genome that function as a basis for protein synthesis within the cells. And an mRNA (messenger RNA) vaccine is a novel type of vaccine for providing acquired immunity through an RNA containing vector, such as lipid nanoparticles. mRNA vaccines and therapeutics integrates the desirable immunological properties and are produced in laboratories using mammalian cells. Upon the int

Pays de la loireUnited statesUnited kingdomCity ofCenters for diseaseEuropean heart networkAmerican heart associationBrand essence market researchTechnology type inactivated vaccineWorld health organizationBio incSangamo therapeutics incArcturus therapeutics incEuropean unionArgos therapeutics incModerna therapeutics inc